Compare ELV & NDAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELV | NDAQ |
|---|---|---|
| Founded | 1944 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.5B | 50.1B |
| IPO Year | 2001 | 2001 |
| Metric | ELV | NDAQ |
|---|---|---|
| Price | $314.76 | $88.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $380.67 | $105.23 |
| AVG Volume (30 Days) | 1.3M | ★ 2.6M |
| Earning Date | 04-22-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.21% | 1.22% |
| EPS Growth | N/A | ★ 60.10 |
| EPS | ★ 25.21 | 3.09 |
| Revenue | ★ $199,125,000,000.00 | $4,277,000,000.00 |
| Revenue This Year | N/A | $10.73 |
| Revenue Next Year | $2.97 | $8.12 |
| P/E Ratio | ★ $12.37 | $28.66 |
| Revenue Growth | ★ 12.49 | 7.87 |
| 52 Week Low | $273.71 | $69.88 |
| 52 Week High | $432.93 | $101.79 |
| Indicator | ELV | NDAQ |
|---|---|---|
| Relative Strength Index (RSI) | 57.58 | 57.15 |
| Support Level | $313.67 | $85.25 |
| Resistance Level | $322.45 | $90.20 |
| Average True Range (ATR) | 8.03 | 2.08 |
| MACD | 2.68 | 0.44 |
| Stochastic Oscillator | 80.35 | 95.80 |
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.